Publications by authors named "Vincent Miller"

100Publications

Attrition of Patients on a Precision Oncology Trial: Analysis of the I-PREDICT Experience.

Oncologist 2020 Sep 19. Epub 2020 Sep 19.

Moores Cancer Center, University of California San Diego, La Jolla, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/onco.13532DOI Listing
September 2020

Clinical, histopathologic, and molecular profiles of PRKAR1A-inactivated melanocytic neoplasms.

J Am Acad Dermatol 2020 Jul 16. Epub 2020 Jul 16.

Foundation Medicine, Inc., 150 Second Street, Cambridge, Massachusetts 02141; Department of Pathology & Laboratory Medicine, Tufts University School of Medicine, 145 Harrison Ave, Boston, Massachusetts 02111.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2020.07.050DOI Listing
July 2020

Pan-Cancer Analysis of Loss-of-Function Alterations and Their Association with the Focal Tandem-Duplicator Phenotype.

Oncologist 2019 12 10;24(12):1526-1533. Epub 2019 Jul 10.

Johns Hopkins University School of Medicine and Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2019-0214DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975947PMC
December 2019

Variable Response to ALK Inhibitors in NSCLC with a Novel MYT1L-ALK Fusion.

J Thorac Oncol 2019 02;14(2):e29-e30

City of Hope Comprehensive Cancer Center, Duarte, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.10.169DOI Listing
February 2019

Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials.

Cancers (Basel) 2018 Dec 21;11(1). Epub 2018 Dec 21.

Department of Medicine, Division of Hematology/Oncology and Center for Personalized Cancer Therapy, University of California San Diego, 3855 Health Science Drive #0987, La Jolla, CA 92093, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11010011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356731PMC
December 2018

Phosphatidylinositol 3-kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities.

Cancer 2019 04 24;125(7):1185-1199. Epub 2018 Dec 24.

Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego, San Diego, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31921DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433468PMC
April 2019

Comprehensive genetic alteration profiling in primary and recurrent glioblastoma.

J Neurooncol 2019 Mar 9;142(1):111-118. Epub 2018 Dec 9.

Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11060-018-03070-2
Publisher Site
http://dx.doi.org/10.1007/s11060-018-03070-2DOI Listing
March 2019

Estimated Cost of Anticancer Therapy Directed by Comprehensive Genomic Profiling in a Single-Center Study.

JCO Precis Oncol 2018 2;2. Epub 2018 Nov 2.

, , and , Analysis Group, Boston; , , and , Foundation Medicine, Cambridge, MA; and and , The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/PO.18.00074DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446484PMC
November 2018

Carving out another slice of the pie: Exceptional response to single agent imatinib in an asian female never-smoker with advanced NSCLC with a de-novo PDGFR-α N848 K mutation.

Lung Cancer 2018 10 31;124:86-89. Epub 2018 Jul 31.

Division of Hematology-Oncology, Department of Medicine, University of California Irvine School of Medicine, Orange, CA 92868, USA; Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, CA 92868, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01695002183050
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2018.07.043DOI Listing
October 2018

Detection of Known and Novel FGFR Fusions in Non-Small Cell Lung Cancer by Comprehensive Genomic Profiling.

J Thorac Oncol 2019 01 26;14(1):54-62. Epub 2018 Sep 26.

Department of Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.09.014DOI Listing
January 2019

Genomic Landscape of Appendiceal Neoplasms.

JCO Precis Oncol 2018 8;2. Epub 2018 Aug 8.

, , , , and , Mount Sinai Hospital, New York, NY; , , , , , , , , , and , University of California, San Diego, La Jolla, CA; , Albany Medical College, Albany, NY; , , and , Foundation Medicine, Cambridge, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/PO.17.00302DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446344PMC
August 2018

Durable Clinical Response to Larotrectinib in an Adolescent Patient With an Undifferentiated Sarcoma Harboring an - Fusion.

JCO Precis Oncol 2018 2;2. Epub 2018 Aug 2.

, , , , and , The University of Texas Southwestern Medical Center; , , , , , , , and , Children's Health, Dallas, TX; , , , , and , Foundation Medicine, Cambridge, MA; and and , Loxo Oncology, South San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/PO.18.00101DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446438PMC
August 2018

Mutations and PD-1 Inhibitor Resistance in -Mutant Lung Adenocarcinoma.

Cancer Discov 2018 07 17;8(7):822-835. Epub 2018 May 17.

Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-18-0099DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030433PMC
July 2018

Real-World Evidence In Support Of Precision Medicine: Clinico-Genomic Cancer Data As A Case Study.

Health Aff (Millwood) 2018 05;37(5):765-772

Amy P. Abernethy is chief medical officer and chief scientific officer at Flatiron Health.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1377/hlthaff.2017.1579DOI Listing
May 2018

in Lung Cancers: Analysis of Patient Cases Reveals Recurrent Mutations, Fusions, Kinase Duplications, and Concurrent Alterations.

JCO Precis Oncol 2018 19;2. Epub 2018 Apr 19.

, Vancouver General Hospital, Vancouver, British Columbia, Canada; , , , , , , , , , , , , , , , , , , and , Foundation Medicine, Cambridge, MA; , The Angeles Clinic and Research Institute and Cedars-Sinai Medical Center, Los Angeles; , University of California San Diego, San Diego; , University of California, San Francisco, San Francisco; and , University of California, Irvine, Medical Center, Irvine, CA; , Cleveland Clinic; and , University Hospitals Cleveland Medical Center and Case Western Reserve University, Cleveland, OH; , Soroka Medical Center and Ben-Gurion University, Beer-Sheve, Israel; , Northwestern University Feinberg School of Medicine Northwestern Medical Center, Chicago, IL; and , Cancer Institute of New Jersey, New Brunswick, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/PO.17.00172DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446447PMC
April 2018

An Observational Study of the Association of Video- Versus Text-Based Informed Consent With Multicenter Trial Enrollment: Lessons From the PALM Study (Patient and Provider Assessment of Lipid Management).

Circ Cardiovasc Qual Outcomes 2018 04;11(4):e004675

Department of Medicine (A.C.F., A.M.N., E.D.P., T.Y.W.) and Duke Clinical Research Institute (A.C.F., A.M.N., E.D.P., T.Y.W., S.L., L.E.W., V.M.,), Duke University Medical Center, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCOUTCOMES.118.004675DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891825PMC
April 2018

Nutritional Ketosis and Mitohormesis: Potential Implications for Mitochondrial Function and Human Health.

J Nutr Metab 2018 11;2018:5157645. Epub 2018 Feb 11.

Department of Human Sciences, College of Education and Human Ecology, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2018/5157645DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828461PMC
February 2018

Impact of EML4-ALK Variant on Resistance Mechanisms and Clinical Outcomes in ALK-Positive Lung Cancer.

J Clin Oncol 2018 04 26;36(12):1199-1206. Epub 2018 Jan 26.

Jessica J. Lin, Satoshi Yoda, Beow Y. Yeap, Ibiayi Dagogo-Jack, Nicholas A. Jessop, Ginger Y. Jiang, Long P. Le, Aaron N. Hata, Justin F. Gainor, Anthony J. Iafrate, and Alice T. Shaw, Massachusetts General Hospital, Boston; Alexa B. Schrock, Kyle Gowen, Philip J. Stephens, Jeffrey S. Ross, Siraj M. Ali, and Vincent A. Miller, Foundation Medicine, Cambridge, MA; Viola W. Zhu and Sai-Hong Ignatius Ou, Chao Family Comprehensive Cancer Center, University of California Irvine School of Medicine, Orange, CA; Melissa L. Johnson, Sarah Cannon Research Institute; and Christine M. Lovly, Vanderbilt-Ingram Cancer Center, Nashville, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.2294DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903999PMC
April 2018

Complete Response to a Fibroblast Growth Factor Receptor Inhibitor in a Patient With Head and Neck Squamous Cell Carcinoma Harboring Amplifications.

JCO Precis Oncol 2018 31;2. Epub 2018 Aug 31.

Ecaterina Ileana Dumbrava, Rasha Alfattal, and Apostolia Maria Tsimberidou, The University of Texas MD Anderson Cancer Center, Houston, TX; and Vincent A. Miller, Foundation Medicine, Cambridge, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/PO.18.00100DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528487PMC
August 2018

Checkpoint inhibitor is active against large cell neuroendocrine carcinoma with high tumor mutation burden.

J Immunother Cancer 2017 09 19;5(1):75. Epub 2017 Sep 19.

Department of Surgery, University of California, San Francisco, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-017-0281-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604145PMC
September 2017